Mileutis
PrivateLast Round
Strategic
May 28, 2024
Momentum Score
25 /100
Company Overview
Mileutis is a biopharmaceutical company that develops natural, non-antibiotic peptides and protein-based therapeutics to treat diseases in animals and humans, with a focus on the dairy industry.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mileutis Comps
Public and private peers based on sector, stage, and business model.
Mileutis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | May 28, 2024 | ||||
| VC Round | Oct 19, 2020 |
Key People
Founding team and executive leadership
Mileutis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NovaQuest Capital Management | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Monthly visitors grew 341% MoM.
- May 28, 2024
Led by Yotvata Dairy
Mileutis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mileutis's valuation, stock price, and market status.
